Effectiveness of antileukemic agents in mice inoculated with a leukemia L1210 variant resistant to 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196).
作者信息
Tyrer D D, Kline I, Gang M, Goldin A, Venditti J M
出版信息
Cancer Chemother Rep. 1969 Sep;53(4):229-41.
PMID:5384463
Abstract
摘要
相似文献
1
2
Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).抗白血病药物对接种了对5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）或5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）耐药的白血病L1210变体的小鼠的有效性。
Cancer Chemother Rep. 1971 Feb;55(1):9-28.
4
5
Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).治疗方案和给药途径对5（或4）-[3,3-双（2-氯乙基）-1-三氮烯基]咪唑-4（或5）-甲酰胺（NSC-82196）治疗小鼠白血病L1210化疗的影响
Cancer Chemother Rep. 1968 Dec;52(7):715-24.
6
Kinetics of the effect of 5(or 4)-(3,3-dimethyl-1-triazeno)-imidazole-4 (or 5) -carboxamide (NSC-45388) and 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196) on the reproductive integrity of cultured leukemia L1210 cells.5（或4）-（3,3-二甲基-1-三氮烯基）-咪唑-4（或5）-甲酰胺（NSC-45388）和5（或4）-[3,3-双（2-氯乙基）-1-三氮烯基]咪唑-4（或5）-甲酰胺（NSC-82196）对培养的白血病L1210细胞生殖完整性影响的动力学
Cancer Chemother Rep. 1968 Dec;52(7):725-32.
7
Complete inhibition of mouse leukaemia L1210 by 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).5（或4）-[3,3-双（2-氯乙基）-1-三氮烯基]咪唑-4（或5）-甲酰胺（NSC-82196）对小鼠白血病L1210的完全抑制作用
Nature. 1966 Apr 9;210(5032):208-9. doi: 10.1038/210208a0.
8
Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.4-(3,3-二甲基-1-三氮烯基)咪唑-5-甲酰胺和3-(3,3-二甲基-1-三氮烯基)吡唑-4-甲酰胺的呋喃基、吡喃基和核糖基衍生物的合成及其抗白血病活性
J Med Chem. 1979 Nov;22(11):1422-5. doi: 10.1021/jm00197a028.
9
Enhanced response of leukemia (L1210) mice to combination chemotherapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) and 5-fluorouracil (NSC-19893).白血病（L1210）小鼠对5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）和5-氟尿嘧啶（NSC-19893）联合化疗的反应增强。
Cancer. 1971 Jun;27(6):1363-8. doi: 10.1002/1097-0142(197106)27:6<1363::aid-cncr2820270614>3.0.co;2-w.
10
Adaptation of a colorimetric determination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) and 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) to blood.5-（3,3-二甲基-1-三氮烯基）-咪唑-4-甲酰胺（NSC-45388）和5-[3,3-双（2-氯乙基）-1-三氮烯基]咪唑-4-甲酰胺（NSC-82196）比色测定法在血液中的适应性。
Cancer Chemother Rep. 1969 Jun;53(3):199-202.
Zotero 插件